| Module 1: Overview of mpox disease, diagnosis & self-protection | World Health Organization (WHO) | 2024 | Training | Anglais |
| Module 2: Mpox vaccines and vaccination strategies for outbreak response | World Health Organization (WHO) | 2025 | Training | Anglais |
| Module 3: Mva-bn vaccine overview | World Health Organization (WHO) | 2024 | Training | Anglais |
| Module 4 : Monitoring mpox vaccination | WHO Regional Office for Africa (AFRO) | 2025 | Training | Anglais |
| Module A - Caractéristiques du vaccin LC16m8 et gestion de la chaîne du froid | World Health Organization (WHO) | 2025 | Training | Français |
| Module A: LC16m8 VACCINE CHARACTERISTICS and cold chain management | World Health Organization (WHO) | 2025 | Training | Anglais |
| Module B Vaccin LC16m8 présentation et administration | World Health Organization (WHO) | 2025 | Training | Français |
| Module B: LC16m8 VACCINE administration & Counselling information for vaccine recipients and caregivers | World Health Organization (WHO) | 2025 | Training | Anglais |
| Sample Mpox Training Objectives and Agenda | World Health Organization (WHO) | 2024 | Training | Anglais |
